Area Riservata
Area Riservata
Tsai SY, Phipatanakul W, Hawryluk EB, Oyoshi MK, Schneider LC, Ma KS. Comparative safety of oral Janus kinase inhibitors versus dupilumab in patients with atopic dermatitis: A population-based cohort study. J Allergy Clin Immunol. 2024 Nov;154(5):1195-1203.e3. doi: 10.1016/j.jaci.2024.07.019. Epub 2024 Aug 7. PMID: 39097196.
Razzaghi H, Garacci E, Kahn KE, Lindley MC, Jones JM, Stokley S, Calhoun K, Black CL. Maternal Respiratory Syncytial Virus Vaccination and Receipt of Respiratory Syncytial Virus Antibody (Nirsevimab) by Infants Aged <8 Months - United States, April 2024. MMWR Morb Mortal Wkly Rep. 2024 Sep 26;73(38):837-843. doi: 10.15585/mmwr.mm7338a2. PMID: 39325675; PMCID: PMC11563570.
Chen, F., Ahimaz, P., Nguyen, Q.M. et al. Phenotype driven molecular genetic test recommendation for diagnosing pediatric rare disorders. Nature Portfolio Journal Digital Med. 7, 333 (2024).
Fox CK, Barrientos-Pérez M, Bomberg EM, Dcruz J, Gies I, Harder-Lauridsen NM, Jalaludin MY, Sahu K, Weimers P, Zueger T, Arslanian S; SCALE Kids Trial Group. Liraglutide for Children 6 to <12 Years of Age with Obesity - A Randomized Trial. N Engl J Med. 2024 Sep 10. doi: 10.1056/NEJMoa2407379 Epub ahead of print. PMID: 39258838
Sostegno per i giovani ricercatori e lavoro di team. Con questo spirito Viviana Moschese, Direttore della U.O.S.D. Immunopatologia e Allergologia Pediatrica del Policlinico Tor Vergata e Professore di Pediatria presso l'Università degli Studi di Roma Tor Vergata, affronta il mandato triennale di Presidente della Società Italiana Ricerca Pediatrica conferitole lo scorso giugno